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ABSTRACT 
 
Wagner DR, Shegrud K, Hintze KJ. ASEA Redox Supplement 
Fails to Improve Aerobic Capacity and Ventilatory Threshold: A 
Double-Blind, Placebo-Controlled Study. JEPonline 2019;22(4):23-
28. The ASEA redox cell signaling supplement beverage has been 
commercially available for the past decade. Despite the market 
longevity of this supplement, athletic sponsorship, and anecdotal 
ergogenic claims, there is no independent, peer-reviewed research 
on its efficacy. The purpose of this study was to determine if ASEA 
improves aerobic capacity (VO2 max) and/or ventilatory threshold 
(VT) of physically active subjects. Eleven (6 females, 5 males) young 
adults (21.9 ± 3.9 yrs) performed 3 VO2 max tests: (a) baseline; (b) 
after 2 wks of supplementing with ASEA; and (c) after 2 wks of 
taking a placebo in a cross-over design. The treatment order was 
randomized and double-blind. The subjects consumed 4 oz∙d-1 (118 
mL∙d-1) of the ASEA treatment according to the manufacturer’s 
recommendations. The subjects’ VO2 max values at baseline (55.0 ± 
8.6 mL·kg-1·min-1), placebo (53.6 ± 9.1 mL·kg-1·min-1), and ASEA 
(53.7 ± 10.1 mL·kg-1·min-1) were not significantly different (P=0.172). 
Similarly, absolute VO2 max (P=0.436), time to reach VO2 max 
(P=0.955), VT as a percentage of VO2 max (P=0.678), and maximal 
heart rate (P=0.410) were not significantly different between trials. 
Contrary to the manufacturer’s claims, ASEA did not improve the 
aerobic performance of young, fit adults who supplemented with the 
product daily for 2 wks. 
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INTRODUCTION 
 
Small physiological changes can result in meaningful improvements in health and physical 
performance. Many people try to achieve these improvements with dietary supplementation. 
Research suggests that 40% to 100% of athletes use supplements, depending on the 
definition of supplements, the level of competition, and the type of sport (4).  
 
One supplement manufacturer that boasts both health and performance claims for its product 
is ASEA. The flagship product of ASEA is the redox cell signaling supplement beverage. 
According to the company, this supplement contains “active redox signaling molecules” that 
serve to protect, rejuvenate, and restore cells (aseaglobal.com). The specific redox signaling 
molecules included in the ASEA beverage are not identified by the manufacturer, but one 
research team noted that this supplement includes hydrogen superoxide, hydrogen peroxide, 
hypochlorous acid, and nitric oxide (7). Knab et al. (6) described this supplement as “a saline 
beverage with stable superoxide complexes.”  
 
ASEA was founded in 2007, and their product has been commercially available for 10 yrs. 
According to their web site, they sponsor 12 athletes that include paralympians, XTERRA and 
Ironman triathletes, and world-class swimmers (https://aseaathletes.co). An in-house 
unpublished report available on the Internet claimed that 4 oz∙d-1 (118 mL∙d-1) of ASEA for 2 
wks improved maximal oxygen consumption (VO2 max) by 3%, time to reach VO2 max by 
10%, and ventilatory threshold (VT) by 12% in a sample of 17 athletes (8). However, this 
research was done without a control group. Also, the proposed mechanism explaining how 
this cell signaling supplement could improve aerobic performance was not provided. Despite 
ASEA being in business for over a decade, sponsorship of elite athletes, and a claim that 
their product improves aerobic capacity, there is a dearth of peer-reviewed, scientific 
research on this supplement. An extensive search of PubMed, Scopus, and GoogleScholar 
revealed only two conference abstracts (6,9) and one foreign language publication (2) related 
to ASEA and aerobic performance. Thus, the purpose of this study was to replicate the 
manufacturer’s in-house report claiming improved aerobic performance with only 2 wks of 
ASEA supplementation (8), but with the addition of a double-blind placebo control using a 
cross-over design. 
 
METHODS  
Subjects 
The subjects were recruited from the university campus community. Inclusion criteria 
included being a regular aerobic exerciser (>150 min∙wk-1), a willingness to take the ASEA 
supplement beverage and a placebo for 2 wks each, and complete 3 VO2 max tests. 
Exclusion criteria included pregnancy and previously taking the ASEA supplement. The 
subjects received the ASEA for free and were compensated $20 for their participation in the 
study. The study was approved by the university’s institutional review board (protocol #7780), 
and all subjects signed a written informed consent before beginning the study. 
 
Design 
The study was double-blind with neither the subjects nor the examiner conducting the VO2 
max testing knowing which beverage, ASEA or placebo, was consumed. A cross-over design 
was used such that each subject received both treatments, serving as his/her own control. 
Additionally, the treatment order (ASEA first or placebo first) was randomly assigned. 
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Procedures 
All subjects underwent a baseline VO2 max test. Following baseline testing, the subjects were 
given a 2-wk supply of a beverage in an unmarked container with a shot glass for measuring 
the proper dosage. Subjects were instructed to take 2 oz (59 mL) in the morning and 2 oz (59 
mL) in the evening (4 oz∙d-1; 118 mL∙d-1), daily, for 2 wks. Immediately before the VO2 max 
test, the subjects consumed 8 oz (237 mL) of the beverage that they had been consuming for 
the previous 2 wks. This is the dosing strategy recommended by ASEA, and it was consistent 
with the protocol of Samuelson (8) from ASEA’s in-house testing. After 2 wks, the VO2 max 
test was repeated. A 1-wk washout period with no treatment followed the second VO2 max 
test. Following the washout week, the subjects were given the opposite treatment of what 
they had received initially for another 2 wks. A third VO2 max test was given at the end of this 
2-wk period. 
 
The ASEA redox supplement was purchased directly from a commercial vendor. According to 
the nutrition label, ASEA contains chloride (Cl) and sodium (Na). The active signaling 
molecules suspended in the saline solution are not listed. To confirm the label ingredients, 
ASEA was analyzed by inductively coupled plasma atomic emission spectroscopy at the 
university’s analytical laboratory. This analysis revealed that ASEA has approximately the 
same amount of NaCl as indicated on the nutrition label. Therefore, the placebo was 
formulated using distilled water and contained the same amount of NaCl as ASEA (313 mg 
per 118 mL serving). The placebo and ASEA were placed into non-descript, coded containers 
by a researcher not involved in the VO2 max test to ensure that both the study subjects and 
researchers conducting the performance tests were blinded to the experimental treatment.    
 
VO2 Max Testing 
The subjects’ height were measured to the nearest 0.1 cm with a wall-mounted stadiometer 
(Seca 216, Seca Corp., Ontario, CA) and weight were measured to the nearest 0.1 kg with a 
digital scale (Seca 869, Seca Corp., Ontario, CA). A ParvoMedics TrueMax 2400 Metabolic 
Measurement System (ParvoMedics, Sandy, UT) was calibrated according to the 
manufacturer’s instructions and used to analyze expired volumes of O2 and CO2 for the 
determination of VO2 max and VT. All subjects ran on a treadmill, but the protocol was 
individualized in an attempt to have each subject reach maximal exertion in approximately 10 
min (1). The speed and incline changes of each individual’s protocol were documented so 
that each individual’s baseline testing protocol was repeated for the subsequent VO2 max 
tests.  
 
Various methods or techniques exist for determining VT, and each technique involves some 
interpretation and subjective judgement (5). To eliminate investigator bias and subjectivity, 
the default VT estimation from the ParvoMedics software was used. This software estimates 
VT automatically using the v-slope method (M. P. Yeh, personal communication, September 
25, 2017), such that VT is the point at which the slope of VO2 consumed plotted against 
VCO2 produced increases from less than 1 to greater than 1. 
 
Statistical Analyses 
 
A priori power analysis (G-Power 3.0.10) for a one-way repeated measures ANOVA (baseline 
v placebo v ASEA) with an alpha of 0.05 and power of 0.80, and assuming a correlation of 
0.90 among the repeated measures suggested a sample size of 10 was sufficient to identify 
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differences with an effect size of 0.20. The normality of the data was evaluated with a 
Shapiro-Wilks test. Means and standard deviations were calculated, and differences in VO2 
max and VT across the three trials were evaluated with a one-way repeated measures 
ANOVA. A P-value of <0.05 was considered statistically significant. All statistical analyses 
were done using SPSS (version 25, IBM, Inc., Armonk, NY).  
 
RESULTS 
 
Twelve subjects were enrolled in the study, but one male suffered an injury unrelated to the 
study and was unable to complete all 3 trials. Therefore, all statistical analyses were done on 
11 subjects (6 females, 5 males). The physically active subjects were homogeneous with 
regard to age (21.9 ± 3.9 yrs) and body mass index (23.7 ± 2.2 kg∙m-2). All data were 
normally distributed (P>0.05) with no statistical outliers. There were no significant within-
subject differences (P>0.05) across trials for relative and absolute VO2 max, time to reach 
maximal exertion, maximal heart rate, and VT (Table 1). 
 
Table 1.  Trial Comparison of Measured Variables. 
     
Variable   Baseline Placebo ASEA P-value 
VO2 max (mL·kg-1∙min-1)   55.0  8.6  53.6  9.1       53.7  10.1 0.172 
VO2 max (L∙min-1)     4.01  0.88   3.94  0.97    3.96  1.06 0.436 
Time to VO2 max (sec)     723  129    721  132    725  112 0.955 
Maximal Heart Rate 
(beats∙min-1) 
 192.1  8.5 190.3  9.8 191.6  6.1 0.410 
Ventilatory Threshold 
(%) 
   72.6  2.1   73.2  4.7   74.3  8.9 0.678 
 
DISCUSSION 
 
The results from this study indicate that daily intake of the ASEA redox supplement for 2 wks 
had no effect on measures of aerobic performance. In fact, the differences in VO2 across 
trials were so small that they were less than the reported test-retest reliability of VO2 testing 
with the ParvoMedics system (3). This study stands in contrast to the in-house report by 
Samuelson (8) and the work by Barghini and Maffi (2). Samuelson (8) reported that about 
70% of the athletes experienced improvements using the same 2-wk ASEA supplementation 
dosing strategy employed in the present study. However, Samuelson (8) had no placebo 
control. Similarly, Barghini and Maffi (2) reported that 9 of 10 recreational runners improved 
their 10 km run time by 2 to 3 min following 3 wks of supplementing 120 mL∙d-1 of ASEA. 
However, again, there was no control group. Thus, the improvement could have been due 
simply to aerobic training. Furthermore, it was discovered that one of the authors served on 
the ASEA science advisory council. To our knowledge, the present study is the first 
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independent, peer-reviewed, placebo-controlled investigation of ASEA’s ability to effect 
aerobic performance to reach publication. 
 
Despite the null result in the present investigation, two conference abstracts by the same 
research lab suggested a potential ergogenic benefit of the ASEA redox supplement. In 2012, 
Shanely et al. (9) reported that only 1 wk of 118 mL∙d-1 of ASEA supplementation enhanced 
fatty acid mobilization over a placebo. However, this did not improve performance on a 75 km 
cycling time trial nor did ASEA alter biomarkers of inflammation, oxidative stress, or immunity. 
The following year, Knab et al. (6) reported that ASEA-supplemented mice run to exhaustion 
had increased skeletal muscle phosphorylated acetyl-CoA carboxylase over placebo mice. 
The ASEA-supplemented mice ran 29% longer than the placebo group, and the authors 
theorized that this was the result of muscle glycogen sparing due to less inhibition of fatty 
acid oxidation. The findings from these two abstracts suggest that the greatest ergogenic 
benefit to ASEA supplementation might be long duration events in which glycogen depletion 
is the limiting factor rather than maximal aerobic efforts as was tested in the present study. 
 
There are claims on the ASEA website that the redox signaling beverage enhances recovery. 
The efficacy of this supplement to speed recovery following aerobic exercise was not part of 
the present study. However, Ryan et al. (7) reported that a single dose of ASEA was 
ineffective at improving recovery from a weight lifting bout or alleviating delayed onset muscle 
soreness. 
 
Strengths and Limitations 
 
This was the first independent, randomized, placebo-controlled, double-blind study of ASEA. 
Thus, the study design and absence of conflict of interest were strengths of this study. While 
2 wks may not be enough time to observe meaningful improvements in VO2 max or VT, this 
time span for supplementation was selected because it matched the study duration used by 
Samuelson (8), and our goal was to replicate the manufacturer’s research. Also, the results 
were limited to the performance variables of VO2 max and VT. The conference abstract of 
Shanely et al. (9) showed that it is possible for the metabolite profiles of ASEA users to be 
altered without changes in aerobic performance. 
 
CONCLUSIONS 
 
In summary, 2 wks of 118 mL∙d-1 (4 oz∙d-1) of the ASEA redox supplement had no effect on 
the aerobic capacity, VT, or time to achieve VO2 max compared to baseline testing and a 
placebo in a group of young, physically active adults. Other claims of the benefits of ASEA 
supplementation, such as extending time to fatigue or enhancing recovery remain untested. 
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